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Akt1 Regulates a JNK Scaffold
during Excitotoxic Apoptosis
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pathway, a stress-induced mitogen-activated protein ki-
nase (MAPK) cascade, plays a causal role in apoptosis
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New York University School of Medicine ing gene-targeted mice indicate that glutamate or kai-
nate exposure activates the JNK pathway in primaryNew York, New York 10016
2 Howard Hughes Medical Institute neurons (DeCoster et al., 1998; Schwarzschild et al.,
1997), which is responsible for subsequent apoptoticDepartment of Internal Medicine
University of Michigan death (Yang et al., 1997). How is an excitotoxicity-spe-
cific JNK response generated? Multiple MAPK kinaseAnn Arbor, Michigan 48109
3 Howard Hughes Medical Institute kinases are capable of phosphorylating two JNK ki-
nases, MKK4 and MKK7, which then activate JNK pro-Department of Internal Medicine
University of Pennsylvania School of Medicine teins (Davis, 2000). Mammalian JNKs are encoded by
three distinct genes, and splice variants exist for eachPhiladelphia, Pennsylvania 19104
isoform. In addition to differential tissue expression and
preferential protein-protein interactions among JNK
pathway components (Cheng et al., 2000; Xia et al.,Summary
1998), scaffold proteins, exemplified by the yeast Ste5
gene product (Elion, 2000), may bind distinct kinaseCell survival is determined by a balance among signal-
ing cascades, including those that recruit the Akt and components, thereby localizing and potentially ampli-
JNK pathways. Here we describe a novel interaction fying a specific JNK signaling module (Whitmarsh et al.,
between Akt1 and JNK interacting protein 1 (JIP1), a 1998).
JNK pathway scaffold. Direct association between The JIP family of JNK scaffolds (also islet-brain [IB] or
Akt1 and JIP1 was observed in primary neurons. Neu- JNK/stress-activated kinase-associated protein [JSAP])
ronal exposure to an excitotoxic stimulus decreased has been suggested to play a critical role in recruiting
the Akt1-JIP1 interaction and concomitantly increased specific JNK signaling pathways (Bonny et al., 1998;
association between JIP1 and JNK. Akt1 interaction Dickens et al., 1997; Ito et al., 1999; Negri et al., 2000;
with JIP1 inhibited JIP1-mediated potentiation of JNK Whitmarsh et al., 1998; Yasuda et al., 1999). Each mem-
activity by decreasing JIP1 binding to specific JNK ber of this scaffold family can bind JNK, MKK7, and a
pathway kinases. Consistent with this view, neurons mixed-lineage kinase (MLK, a MAPKKK family) on differ-
from Akt1-deficient mice exhibited higher susceptibil- ent regions of JIP (Kelkar et al., 2000; Whitmarsh et al.,
ity to kainate than wild-type littermates. Overexpres- 1998; Yasuda et al., 1999). Experiments using transiently
sion of Akt1 mutants that bind JIP1 reduced excito- transfected cell lines have suggested that JIP1 can am-
toxic apoptosis. These results suggest that Akt1 plify MLK-induced JNK activation (Whitmarsh et al.,
binding to JIP1 acts as a regulatory gate preventing 1998). Recent evidence from mice genetically deficient
JNK activation, which is released under conditions of in JIP1 has demonstrated that this scaffold is a stimulus-
excitotoxic injury. specific, positive regulator of JNK activity in vivo (Whit-
marsh et al., 2001). Significantly, JIP1 gene deletion con-
Introduction ferred higher resistance to kainate-induced neuronal
death in mice and neuronal culture, indicating that JIP1
Overactivation of ionotropic glutamate receptors can plays an important role in AMPA/kainate receptor-medi-
induce neuronal death, a phenomenon known as excito- ated apoptotic signaling.
toxicity (Choi, 1992). This process has been implicated JNK activity can be antagonized by Akt kinase activity
as a pathophysiological factor in multiple neurological in numerous cell systems, and this crosstalk may under-
disorders, both acute, such as stroke and seizure, and lie many of the prosurvival effects of Akt (Cerezo et al.,
chronic, such as neurodegenerative diseases (Kerchner 1998; Kim et al., 2001; Okubo et al., 1998; Sarmiere
et al., 1999). Glutamate activates three major subgroups and Freeman, 2001). The Akt family of Ser/Thr-directed
of ionotropic receptors, N-methyl-D-aspartate (NMDA), protein kinases (Akt1-3 or protein kinase B -) are im-
-amino-3-hydroxy-5-methylisoxazole-4-propionic- portant mediators of cell survival in response to growth
acid (AMPA), and kainate receptor-gated channels (Holl- factors and stimuli that elicit calcium influx (Dudek et
mann and Heinemann, 1994; Nakanishi and Masu, 1994). al., 1997; Yano et al., 1998). Akt kinases have been sug-
Kainate, a model excitotoxin, activates both AMPA and gested to phosphorylate a number of proapoptotic pro-
kainate receptor subtypes and can induce seizures and teins directly, thereby leading to suppression of death
hippocampal neuronal apoptosis in vivo (Ferkany et al., signals (Datta et al., 1999; Lawlor and Alessi, 2001).
1984; Pollard et al., 1994; Schreiber et al., 1993) as well Here we describe a novel mechanism of Akt-JNK
as trigger cell death in cultured primary neurons (Koh crosstalk in neurons undergoing excitotoxic apoptosis.
et al., 1990). We provide evidence that Akt1 binding to JIP1 de-
creases JIP1’s ability to enhance JNK activity by inter-
fering with JIP1-mediated assembly of an active JNK4 Correspondence: chao@saturn.med.nyu.edu
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signaling complex. Excitotoxic kainate exposure de- from hippocampal neuronal lysates. A clear association
was found with JIP1 (Figure 2A). As a test for specificity,creases the neuronal interaction between Akt1 and JIP1
and increases formation of JNK-JIP1 complexes, sug- preincubation of the Akt1 antibody with the immunogen
peptide eliminated the immune complex. An endoge-gesting that Akt1 interaction with JIP1 acts as a negative
switch for JNK activity. Consistent with this model, Akt1 nous Akt1-JIP1 association was also observed in lysates
derived from cultured cortical neurons (data not shown).gene deletion rendered neurons more susceptible to
kainate-induced neuronal death, and ectopic expres- Together with the coincident distribution in neurons, the
endogenous interaction between Akt1 and JIP1 furthersion of Akt1 binding mutants decreased kainate toxicity.
supports the hypothesis that this interaction results in
functional consequences.Results
Kainate-induced JNK activation and subsequent neu-
ronal apoptosis is attenuated by JIP1 gene deletion,Akt1 Colocalizes with JIP1 in Primary Neurons
indicating a key role for JIP1 in this process (WhitmarshThe mechanisms that mediate crosstalk between Akt
et al., 2001). We hypothesized that the endogenousand JNK signaling are not well understood. We focused
Akt1-JIP1 interaction may be regulated during an excito-on a critical JNK scaffold protein, JIP1, given the recent
toxic insult. Hippocampal neurons were treated for 30pathophysiological finding that JIP1 is required for exci-
min with vehicle or kainate (50 or 100 M), exposurestotoxic neuronal apoptosis in culture and in vivo (Whit-
that caused neurodegeneration over the next 24 hr. Cellmarsh et al., 1998, 2001). To test whether Akt1 and
lysates were assessed for Akt1-JIP1 interaction by co-JIP1 are coexpressed in a similar pattern in neurons,
precipitation (Figure 2A). Kainate exposure at both con-we visualized these proteins in primary hippocampal
centrations substantially decreased the endogenous as-neurons by indirect immunofluorescence followed by
sociation between Akt1 and JIP1. Considering the JNKconfocal microscopy (Figure 1). As reported previously,
scaffold function of JIP1 and the existence of Akt1, JNK,JIP1 was expressed in a punctate, neuritic distribution
and JIP1 within the same subcellular fractions (Figure(Figure 1A) (Meyer et al., 1999; Pellet et al., 2000), with
1F), we hypothesized that Akt1 dissociation from JIP1a subpopulation of JIP1 colocalizing with the somato-
may be associated with alterations in JIP1 binding todendritic marker, MAP2 (data not shown). Akt1 was lo-
JNK. JNKs 1 and 3 were immunoprecipitated from ly-calized throughout the soma and neurites in a dense
sates prepared from vehicle- and kainate-treated hippo-speckled pattern, with some areas of larger punctate
campal neurons and subjected to anti-JIP1 immunoblot-immunoreactivity (Figure 1B). A substantial fraction of
ting (Figure 2B). JIP1 was not found to bind JNKs 1 andJIP1 protein colocalized with the larger Akt1-immunore-
3 significantly in untreated neurons. However, followingactive punctae (Figures 1C and 1D). A similar pattern
30 min of kainate (100 M) stimulation, JIP1 protein inof Akt1 and JIP1 expression was observed in primary
JNK immunoprecipitates was markedly elevated. Thesecortical neurons (data not shown).
binding changes could not be accounted for by differ-To confirm this colocalization using an alternative ap-
ences in lysate Akt1, JNK, or JIP1 levels (Figure 2C).proach, primary hippocampal neurons were subjected
Similar results were obtained after exposing neurons toto subcellular fractionation (Figure 1E, top). Initial frac-
50 M of kainate (data not shown). The coimmunopreci-tionation results indicated that JIP1 localized predomi-
pitation results suggested that Akt1 binding preventednantly to the P2 membrane fraction (Figure 1E, bottom).
JIP1 interactions with the JNK pathway and that excito-A substantial portion of neuronal Akt1 was also found
toxic stimulation released the JNK scaffold from Akt1.in this fraction. Linear gradient centrifugation of JIP1-
To test whether kainate-induced reduction of Akt1-enriched P2 demonstrated that JIP1 and Akt1 reside in
JIP1 binding is the consequence of changes in Akt1equivalent fractions, suggesting that these proteins ex-
activity, the phosphorylation status of critical Akt regula-ist in the same membrane compartment (Figure 1F, frac-
tory sites was assessed. Hippocampal neurons weretions 7–12). In discontinuous gradient experiments,
treated with or without 100 M kainate for 30 min, andthese JIP1- and Akt1-containing fractions correspond
crude lysates or anti-Akt1 immunoprecipitates wereto interfaces between 5%–10% of iodixanol (data not
probed with anti-phosphospecific Akt antibodies (Figureshown). Intriguingly, these fractions also contained
2D). Notably, phosphorylation of neither the Akt1 activa-JNKs 1 and 3, AMPA/kainate receptor subunits (GluR2
tion loop (T308) nor total lysate Akt at the regulatory Cand GluR6/7), and PSD-95, implying that postsynaptic
terminus (S473), two sites that reflect Akt activity, wasproteins and JIP1-associated signaling molecules are
changed by kainate stimulation. Further time course ex-in close proximity to JIP1 and Akt1. Significantly, ribo-
periments with kainate-treated neurons (100M, 30 min)phorin, an endoplasmic reticulum-resident protein, was
revealed no change in total lysate Akt activity, as as-not observed in JIP1- and Akt1-enriched fractions.
sessed by anti-phospho-Akt S473 immunoblotting, evenTaken together, the immunofluorescence and fraction-
6 hr following toxic exposure (data not shown). Addition-ation results suggest that JIP1 and Akt1 may interact
ally, examination of the neuronal Akt1-JIP1 interactionwith each other within a specific membrane com-
following BDNF treatment (50 ng/ml, 20 min), which acti-partment.
vates the Akt family, did not cause a change in Akt1-
JIP1 binding (data not shown). These results imply thatKainate Exposure Reduces the Akt1-JIP1
Akt1 activity may not regulate Akt1 interactions with JIP1.Interaction and Increases the JNK-JIP1
Interaction in Primary Hippocampal Neurons
Given the colocalization of Akt1 and JIP1 in neurons, we Akt1 Interacts Directly with JIP1
To examine the requirements of Akt1-JIP1 association,next evaluated whether these proteins form a physical
complex. Endogenous Akt1 was immunoprecipitated we performed further coimmunoprecipitation experi-
Akt1 Regulates JIP1
699
Figure 1. Colocalization of Akt1 and JIP1 in Primary Hippocampal Neurons
(A and B) Rat DIV 11 hippocampal neurons were subjected to indirect immunofluorescence using (A) anti-JIP1 (green) and (B) anti-Akt1 (red).
Proteins were visualized by confocal fluorescence microscopy.
(C and D) Coincident Akt1 and JIP1 signals are depicted in the image overlays (yellow). Scale bar  10 m for (A)–(C) and 5 m for (D).
(E) Subcellular fractionation of DIV 11 hippocampal neurons was performed as depicted in the diagram (top). Proteins were analyzed in each
fraction by immunoblotting (bottom panels). S, supernatant; P, pellet.
(F) JIP1, Akt1, JNK1/3, GluR6/7, GluR2, and PSD-95 are present within the same fractions in a 0%–25% linear iodixanol gradient using P2.
Equal volumes of the 25 collected fractions were analyzed by immunoblotting.
ments in 293 cells transiently transfected with epitope- deletion constructs were assessed by coprecipitation
(Figures 3B and 3C). The results mapped the JIP1 bind-tagged Akt and JIP1 constructs. Using this assay, com-
parison of Akt1 and Akt2, which share approximately ing region on Akt1 to amino acids 61–112, which repre-
sent sequences within the pleckstrin homology (PH) do-90% amino acid similarity (Cheng et al., 1992), unexpect-
edly revealed isoform-specific differences in relative main. Consistent with these results, a kinase-dead Akt1
(HA-Akt1KD) construct and three different constitutivelybinding affinity for JIP1, with Akt1 binding with higher
affinity than Akt2 (Figure 3A). Upon close inspection of active Akt constructs (HA-Akt1E40K, myristoylated-
Akt1-HA, and HA-Akt1T308D/S473D) also bound to im-the amino acid sequence of the Akt isoforms, we noted
that the amino and carboxyl termini of the Akt proteins munoprecipitated JIP1 (data not shown). Reciprocal co-
precipitation experiments with a series of JIP1 deletionexhibit notable sequence divergence. A series of Akt1
Neuron
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Figure 2. Effect of Kainate upon Akt1-JIP1
Binding in Primary Hippocampal Neurons
(A) Rat DIV11 hippocampal neurons treated
with () or without () kainate (KA; 50 or 100
M) for 30 min were lysed and analyzed by
immunoprecipitation (IP) with anti-Akt1 fol-
lowed by Western blotting (W). “Peptide” de-
notes preincubation of the immunoprecipita-
tion antibody with excess immunogen
peptide.
(B) Cell lysates treated with 100 M of KA as
in (A) were analyzed by immunoprecipitation
with anti-JNK1/3 followed by Western blot-
ting with anti-JIP1. “IgG” represents immuno-
precipitation using normal rabbit IgG.
(C) The crude lysates (Lys) used for immuno-
precipitations in (A) and (B) were examined
by immunoblotting.
(D) Neurons treated with 100 M of KA for
the indicated time were lysed, and anti-Akt1
immunoprecipitates were probed with anti-
phospho-Thr308 Akt (PT308) (upper panels).
Lysates were probed with anti-phospho-
Ser473 Akt (PS473) (lower panels).
constructs identified two potential Akt1 binding sites in activated JNK1 to a small degree (Figure 4A, lane 2).
Consistent with previous literature (Whitmarsh et al.,JIP1, one within amino acids 287–487 and the other
within amino acids 488–711 (Figures 3B and 3D). These 1998), this JNK response was greatly enhanced by JIP1
coexpression (Figure 4A, lane 7). Significantly, expres-cellular binding studies indicate that the Akt1-JIP1 inter-
action depends upon specific sequence requirements sion of Akt1 and Akt2 constructs did not alter MLK3-
mediated activation of JNK1 (Figure 4A, lanes 2–5). How-within both proteins.
Coimmunoprecipitation experiments do not distin- ever, JIP1-induced potentiation of JNK1 activity was
clearly inhibited by coexpression of wild-type Akt1 (Fig-guish between direct and indirect protein-protein inter-
actions. To test the possibility of a direct interaction, a ure 4A, lane 8). Intriguingly, coexpression of a kinase-
dead Akt1 construct similarly inhibited JIP1-inducedglutathione S transferase (GST) pull-down assay was
used with recombinant GST-Akt1 fusion protein and 35S- JNK potentiation (Figure 4A, lane 9), suggesting the ac-
tion of Akt1 did not depend on its catalytic activity.methionine-labeled JIP1 deletion mutants (Figure 3B)
translated in vitro (Figure 3E). GST was used as a nega- Coexpression of wild-type Akt2 did not block JIP1-medi-
ated enhancement of JNK activity (Figure 4A, lane 10),tive control for each pull down. The results of the GST
pull-down assays were qualitatively similar to the co- which correlates with Akt2’s lower binding affinity for
JIP1 compared to that of Akt1. This suggests that theprecipitation experiments, in that two Akt1 binding sites
were identified in nonoverlapping deletions (as above, binding of Akt1 to JIP1 is a key regulator of JIP1 function.
To demonstrate more directly that inhibition of JIP1within JIP1 amino acids 287–487 and amino acids 488–
711). These in vitro binding experiments indicate that scaffold function occurs in a binding-dependent man-
ner, we tested whether Akt1 mutants that specificallyAkt1 can directly bind JIP1. Collectively, the cellular and
in vitro binding studies suggest that the endogenous bind JIP1 could also diminish JIP1-mediated enhance-
ment of JNK activity (Figure 4B). Indeed, coexpressionneuronal complex of Akt1 and JIP1 reflects a specific
and direct interaction between the two proteins. of an Akt1 deletion containing only the JIP1 binding
region (HA-Akt1 AH) decreased JIP1-medated JNK
potentiation (Figure 4B, lanes 3 and 4), whereas a com-Akt1 Inhibits JIP1-Mediated Potentiation
plementary fragment that does not bind JIP1 (HA-of JNK Activity
Akt1250) did not affect this potentiation (Figure 4B,To assess whether Akt1 regulates JIP1 function, we
lanes 3 and 5). Taken together, these results suggestassessed the ability of Akt1 to influence JIP1-mediated
that Akt1 binding acts to inhibit the ability of JIP1 to actpotentiation of JNK activity. A previous report by Savi-
as a JNK signaling scaffold.nainen et al. (2001) demonstrated that MLK3 could medi-
ate kainate-induced JNK activation and neuronal death.
We, therefore, ectopically expressed MLK3 as a model Akt1 Binding to JIP1 Decreases Formation
of an Active JNK Signaling ComplexMAPKKK to trigger JNK pathway activation in COS7
cells. JNK activity was assessed using anti-phospho- Given the association of JNK scaffold inhibition with
Akt1 binding, we hypothesized that Akt1 could competeJNK immunoblotting, which detects activating phos-
phorylations on JNK Thr183 and Tyr185 (Figure 4). MLK3 with one or more of the JNK pathway kinases for JIP1
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Figure 3. Binding of Akt1 to JIP1
(A) Lysates from cells transfected with the
indicated constructs were analyzed by anti-
myc immunoprecipitation (IP) followed by
Western blot analysis (W) (upper panels).
Crude lysates (Lys) were probed by Western
blotting (lower panels).
(B) Diagrams of the Akt1 (upper box) and JIP1
(lower box) deletion mutants are depicted.
PH, pleckstrin homology domain; JBD, JNK
binding domain of JIP1; SH3, src homology
domain 3; PTB, phosphotyrosine binding
domain.
(C) Cells transfected with the indicated con-
structs were lysed and examined by anti-
FLAG immunoprecipitation followed by West-
ern blotting (upper panels). Crude lysates
were probed by immunoblotting (lower pan-
els). WT, wild-type.
(D) Cells transfected with the indicated con-
structs were lysed and examined by anti-HA
immunoprecipitation followed by Western
blotting (upper panels). Crude lysates were
probed by immunoblotting (lower panels).
(E) In vitro translated, 35S-methionine-labeled
JIP1 mutant proteins were used to perform a
GST pull-down assay using recombinant
GST-Akt1 and GST proteins (left panel). The
middle panel (Input) confirms that the JIP1
mutants were produced at comparable lev-
els. JIP1 proteins were visualized by autoradi-
ography. Similar amounts of GST and GST-
Akt1 were used for the pull downs as shown
by Coomassie blue staining (CB; right panel).
binding and thereby prevent efficient JNK activation. not likely compete with JNK1 or MKK7, either singly or
in combination, for JIP1 binding.JIP1 has been shown to interact directly with JNK,
MKK7, and MLK, each on distinct sites of JIP1 (Whit- The ability of Akt1 to regulate MLK3 interactions with
JIP1 was tested through a similar coprecipitation ap-marsh et al., 1998). Coimmunoprecipitation experiments
were therefore performed using lysates from transiently proach in COS7 cells (Figure 5B). In MLK3 and JIP1
cotransfected cells, MLK3 binding to JIP1 was not di-transfected COS7 cells to test if JIP1 binding to JNK
cascade kinases could be diminished by Akt1 coexpres- minished by Akt1 overexpression, as was the case with
JNK1 and MKK7 (Figure 5B, lanes 3 and 4). We thension (Figure 5). Neither JNK1 nor MKK7 binding to immu-
noprecipitated JIP1 was decreased by Akt1 expression examined MLK3 binding to JIP1 in the presence of JNK1.
Interestingly, JNK1 coexpression increased MLK3 bind-(Figure 5A, lanes 3–6). Similarly, Akt1 expression had no
effect on JIP1 binding to these JNK pathway kinases ing to JIP1 compared to MLK3 expression alone (Figure
5B, lanes 3 and 5). Additionally, JNK1 binding to JIP1when MKK7 and JNK were coexpressed (Figure 5A,
lanes 7 and 8). These results indicated that Akt1 does was increased by MLK3 coexpression compared to
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tates exhibited relatively higher activity than JNK1 in
crude lysates (Figure 5B, lane 5), suggesting that JIP1
assembles an active JNK signaling pathway.
We hypothesized that this active JNK scaffold com-
plex could be disrupted by Akt1 binding. Indeed, when
MLK3, JNK1, and JIP1 were coexpressed, Akt1 overex-
pression decreased the cooperative binding of both
MLK3 and JNK1 to JIP1 (Figure 5B, lanes 5 and 6).
Moreover, this effect on binding was associated with a
decrease in both JIP1-bound and lysate JNK activity
(Figure 5B, lanes 5 and 6). Coexpression of wild-type
or kinase-dead Akt1 also reduced formation of a JIP1-
mediated ternary complex between MLK3 and JNK1
(Figure 5C, lanes 3–5), highlighting again the critical role
of Akt1 binding to JIP1. Taken together, these experi-
ments demonstrate that Akt1 binding to JIP1 inhibits
JIP1’s ability to assemble active JNK signaling com-
plexes.
Primary Neurons Derived from Akt1 Mutant
Mice Exhibit Enhanced Vulnerability
to Kainate-Induced Cell Death
The biochemical and transfection experiments suggest
that Akt1 binding to JIP1 may exert a survival effect
during kainate-induced death by decreasing stimulated
JNK activity. To establish the physiological relevance
of these observations, we tested if neurons genetically
deficient in Akt1 are more susceptible to kainate expo-
sure. Cell death experiments were performed using pri-
mary hippocampo-cortical neurons derived from Akt1
heterozygous and homozygous null mice, with wild-type
littermates as controls (Figure 6) (Cho et al., 2001). Initial
experiments demonstrated that Akt1 gene deletion al-
tered neither ambient neuronal death nor the near com-
plete death caused by 30 M of A23187, a calcium
Figure 4. Akt1 Inhibits JIP1-Mediated Potentiation of JNK1 Activa- ionophore, compared to wild-type controls (data not
tion in COS7 Cells shown).
(A) Akt1 specifically inhibits JIP1-mediated potentiation of JNK ac- Primary neurons were treated with 25 or 50 M of
tivity. Cells were transfected with the indicated constructs, and kainate for 30 min and then incubated in fresh medium
crude lysates were examined for JNK activity with a phospho-spe- for 24 hr at 37C (Figure 6A). At 50 M of kainate, Akt1
cific JNK antibody (PJNK) by Western blotting (W) (top panel).
homozygous null neurons displayed significantly greaterLevels of transfected proteins were also assessed by Western blot-
vulnerability to kainate toxicity, with Akt1/ neuronsting (lower panels).
exhibiting a 43% increase in cell death (54.46%) com-(B) Akt1 deletion mutants inhibit JIP1-mediated enhancement of
JNK activity. Cells transfected with the indicated constructs were pared to Akt1/ neurons (38.1%). Cell death in Akt1/
analyzed as in (A). HA-Akt1 AH, Akt1 amino acids 1–147; HA- neurons exposed to 50 M of kainate was intermediate
Akt1250, Akt1 amino acids 250–480. (47.4%) between that of Akt1/ and Akt1/ neurons.
Following exposure to 25M of kainate, Akt1/ neurons
exhibited a low level of cell death (10.4%). At this lowerJNK1 alone (Figure 5B, lanes 2 and 5). These results
suggested that MLK3 and JNK1 bind JIP1 in a positively kainate concentration, the vulnerability of both Akt1/
and Akt1/ neurons was significantly higher than that ofcooperative manner. Consistent with a cooperativity
mechanism, coexpressed JIP1 was found to increase wild-type neurons. Akt1 heterozygous and homozygous
null neurons demonstrated a 2.8-fold (29.6%) and 3.4-complex formation between MLK3 and JNK1 in trans-
fected COS7 cells (Figure 5C, lanes 2 and 3), indicating fold (35.1%) enhancement in cell death, respectively,
compared to littermate controls. The higher susceptibil-that JIP1 can bind both kinase components at the same
time. To determine if the synergistic binding of MLK3 ity of even Akt1 heterozygous null neurons to excitotoxic
neurodegeneration indicates that the level of Akt1 pro-and JNK1 to JIP1 is associated with JNK activation on
the scaffold, the activity of both the JIP1-bound and tein has an influence upon neuronal survival, consistent
with an Akt1 binding mechanism.lysate pools of JNK1 were assessed by anti-phospho-
JNK immunoblotting (Figure 5B). Both JIP1-bound and The gene dosage effect of Akt1 on kainate-induced
apoptosis correlated with the amount of Akt1 protein inlysate JNK1 were inactive in the absence of MLK3 (Fig-
ure 5B, lane 2). As shown above, addition of JIP1 potenti- neuronal lysates (Figure 6B). No differences in protein
expression of the kainate receptor subunits GluR6 andated MLK3-induced JNK activation in cell lysates. In this
JIP1-potentiated context, JNK1 in JIP1 immunoprecipi- 7, AMPA receptor subunit GluR2, JIP1, and JNKs 1 and
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Figure 5. Akt1 Diminishes JIP1-Mediated
Scaffolding of the JNK Pathway in COS7 Cells
(A) MKK7 and JNK do not compete with Akt1
for JIP1 binding. Cells transfected with the
indicated constructs were lysed and exam-
ined by immunoprecipitation (IP) with anti-
FLAG followed by Western blotting (W) (upper
panels). Crude lysates (Lys) were probed by
Western blotting (lower panels).
(B) MLK3 and JNK1, only in combination,
compete with Akt1 for JIP1 binding. Cells
transfected with the indicated constructs
were lysed and examined by immunoprecipi-
tation with anti-myc followed by Western
blotting (upper panels). Crude lysates were
probed by Western blotting (lower panels).
(C) Akt1 expression inhibits JIP1’s ability to
mediate ternary complex formation between
MLK3 and JNK1. Cells transfected with the
indicated constructs were lysed and exam-
ined by immunoprecipitation with anti-FLAG
followed by Western blotting (upper panels).
Crude lysates were probed by Western blot-
ting (lower panels).
3 were detected in neuronal cultures with different Akt1 of active, nuclear JNK compared to wild-type neurons.
These results strengthen the hypothesis that Akt1,genotypes (Figure 6B). Potentiation of kainate-induced
neuronal death by Akt1 gene deletion supports a critical through interactions with JIP1, attenuates kainate-
induced JNK activation and subsequent apoptosis.biological role for Akt1 in this pathophysiological
process.
To test whether this enhanced vulnerability of Akt1 Ectopic Akt1 Expression Attenuates Kainate-
Induced Apoptosis in Hippocampal Neuronsgene-deleted neurons was associated with increased
JNK activation, we established an assay to examine To evaluate the specificity of Akt1-JIP1 binding under
excitotoxic conditions, we assessed kainate-induceddynamic, kainate-induced JNK activity in primary neu-
rons by anti-phospho-JNK immunofluorescence (Figure apoptosis using rat hippocampal neurons cotransfected
with a 	-gal marker plasmid and epitope-tagged Akt6C). Neurons were exposed to 25 M of kainate for
30 min and incubated at 37C for 6 hr. This kainate and JIP1 constructs. Initial experiments indicated that
a substantial proportion of kainate-triggered death (25concentration was selected due to the dramatic differ-
ence in cell death between Akt1 wild-type and homozy- or 100M) in these cultures is sensitive to pharmacolog-
ical caspase inhibition (ZVAD-FMK) (Figure 7A), indicat-gous null neurons, as demonstrated above. Although
basal JNK activity was detectable in the neurites of both ing that kainate can act as an apoptotic stimulus in this
model system. Transfected neurons were exposed toAkt1/ and Akt1/ neurons, nuclear accumulation of
anti-phospho-JNK immunoreactivity was not apparent kainate (100 M) for 30 min and incubated in fresh me-
dium for an additional 24 hr. Neurons were then fixedin either vehicle-treated Akt1/ or Akt1/ neurons. Six
hours after kainate treatment, however, nuclear accu- and subjected to anti-	-gal immunofluorescence to
mark transfected neurons. Apoptosis in 	-gal-positivemulation of active JNK occurred in 23.1% of Akt1/
neurons, as opposed to 2.5% of Akt1/ neurons. There- cells was assessed by scoring for apoptotic nuclear
morphology and evidence of neuritic degeneration (Fig-fore, the enhanced cell death observed with Akt1-defi-
cient neurons was preceded by increased accumulation ure 7B).
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Figure 6. Akt1 Gene Deletion Augments Neu-
ronal Susceptibility to Kainate-Induced Tox-
icity
(A) DIV 10 hippocampo-cortical neurons were
prepared by single-embryo dissection of
E15–E16 mouse embryos. Cells were ex-
posed to vehicle, 25 M of kainate (KA), or
50 M of kainate for 30 min at 37C and then
incubated in fresh medium for an additional
24 hr at 37C. Cell death was assessed by
LDH efflux and normalized as described in
the Experimental Procedures. All bars depict
mean SEM (n 4–7 embryos per condition,
each in triplicate). *p
 0.05, significant differ-
ence from Akt1/ neurons treated with 25
M of kainate (bar 1); #p 
 0.05, significant
difference from Akt1/ neurons treated with
50 M of kainate (bar 4). Statistical analysis
was performed using one-way ANOVA fol-
lowed by a Bonferroni t test.
(B) Whole cell-lysates from neurons prepared
as in (A) were processed for immunoblotting
with the indicated antibodies.
(C) Kainate exposure causes increased nu-
clear accumulation of active JNK in Akt1/
neurons and not in Akt1/ neurons. On the
left, Akt1 wild-type (top panels) and homozy-
gous null (bottom panels) neurons (prepared
as in [A]) were exposed to vehicle or 25 M
of kainate for 30 min at 37C and then incu-
bated in fresh medium for an additional 6 hr
at 37C. Cells were then subjected to indirect
immunofluorescence with anti-phospho-JNK
(red) and Hoechst 33342 nuclear staining
(blue). Scale bar  10 M. On the right, the
percentage of anti-phospho-JNK-positive
nuclei 6 hr following kainate exposure was
quantitated in a blind fashion and expressed
as means  SEM from three independent ex-
periments. *p 
 0.02, significant difference
from Akt1/ neurons (Student’s t test).
Using this system, kainate triggered apoptosis in 42% higher with these constructs, presumably due to inter-
ference with Akt kinase-mediated survival under basalof vector-transfected neurons (Figure 7C). To confirm
the JNK dependence of this paradigm, neurons were conditions (Dudek et al., 1997; Khwaja et al., 1997). As
a test for specificity, transfection of an Akt1 deletiontransfected with a JIP1 deletion construct containing
the JNK binding domain (FLAG-JIP1A). Previous reports construct that does not bind JIP1 (HA-Akt1250) did
not alter the extent of kainate-induced death comparedhave demonstrated that similar deletion mutants act as
effective and specific JNK inhibitors (Dickens et al., to that of vector-transfected neurons. Consistent with
the COS7 cell data, introduction of Akt2 also did not1997; Eilers et al., 2001; Harding et al., 2001). Expression
of this JIP1 deletion inhibited kainate-induced apoptosis significantly attenuate kainate-induced apoptosis com-
pared to vector transfection. Kainate-induced death inby 50%, confirming a causal role for JNK activity in this
process. Wild-type Akt1 transfection inhibited kainate- Akt2-transfected neurons was significantly higher than
in Akt1-transfected neurons, indicating a biological, asinduced cell death to a similar extent, consistent with
increased Akt1-mediated inhibition of JNK scaffolding. well as biochemical, difference between these two iso-
forms. Together with the above cell line experiments,This experiment, however, does not distinguish between
Akt1 binding and kinase activity as the prosurvival these results indicate that JNK scaffold inhibition by
Akt1 is due specifically to Akt1 binding to JIP1.mechanism.
To test the impact of Akt1 binding in this apoptotic
process, additional Akt1 or Akt2 constructs were trans- Discussion
fected into hippocampal neurons (Figure 7C). Transfec-
tion of both a kinase-dead Akt1 construct or an Akt1 The current study indicates that Akt1 binding to JIP1
decreases JIP1’s ability to scaffold a JNK signaling mod-deletion construct containing the JIP1 binding site (HA-
Akt1 AH) attenuated kainate-induced apoptosis by ap- ule in primary neurons (Figure 8). This mechanism is
supported by several lines of evidence. First, an endoge-proximately 30%. Ambient cell death was somewhat
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Figure 7. Ectopic Akt1 Protects Primary Hip-
pocampal Neurons against Kainate-Induced
Apoptosis Independent of Kinase Activity
(A) Rat neurons were preincubated with either
vehicle (Veh  DMSO) or 100 M of ZVAD-
FMK (ZVAD) for 30 min, exposed to the indi-
cated KA concentrations for 30 min, and then
incubated in fresh medium containing vehicle
or ZVAD for 24 hr. Cell death was assessed
by LDH efflux and normalized as described
in the Experimental Procedures. No differ-
ence in basal death was noted between vehi-
cle- and ZVAD-treated cultures. Data repre-
sent means  SEM from five independent
experiments. *p
 0.05, significant difference
from neurons treated with vehicle at the cor-
responding KA concentration (Student’s t
test).
(B) Rat neurons cotransfected with the indi-
cated epitope-tagged constructs and 	-gal
marker plasmid were treated with either vehi-
cle () or 100 M of kainate () for 30 min at
37C and then incubated in fresh medium for
24 hr at 37C. Cells were then fixed and
stained with anti-	-gal (	gal) and nuclear
label (Hoechst 33342). 	-gal-positive neurons
were assessed in a blind fashion for apopto-
sis by scoring nuclear morphology and neu-
ritic degeneration. Representative neurons
are shown. Scale bar  10 m.
(C) Neurons were treated as in (B). Histogram
represents mean  SEM from four indepen-
dent experiments (n 5–8). *p
 0.05, signifi-
cant difference from vector-transfected, kai-
nate-treated neurons (bar 2); #p 
 0.05,
significant difference from HA-Akt1-trans-
fected, kainate-treated neurons (bar 6) (one-
way ANOVA followed by a Bonferroni t test).
Vec, vector; FLAG-JIP1A, JIP1 amino acids
1–286; HA-Akt1KD, kinase-dead Akt1; HA-
Akt1 AH, Akt1 amino acids 1–147; and HA-
Akt1250, Akt1 amino acids 250–480.
nous interaction between Akt1 and JIP1 in primary (Davis, 2000). Mice harboring a mutant allele of c-jun
with Ser63 and Ser73 mutated to alanines (renderingneurons was detected. Second, kainate induced disso-
ciation of Akt1 and JIP1 and increased formation of c-jun insensitive to JNK phosphorylation) also exhibit
increased resistance to neuronal kainate toxicity in cul-JNK-JIP1 complexes in hippocampal neurons. Third,
experiments in COS7 cells revealed that Akt1 binding ture and in vivo (Behrens et al., 1999). Whitmarsh et al.
(2001) recently reported that JIP1 homozygous null miceto JIP1 specifically decreases JIP1-mediated assembly
and potentiation of the JNK pathway, independent of and primary neurons demonstrate a similarly increased
resistance to kainate-induced death. This finding con-Akt1 kinase activity. Finally, the physiological role of the
Akt1-JIP1 interaction was verified by complementary firmed a role for JIP1 as a positive regulator of the JNK
pathway in vivo and identified JIP1 as a componentcell death experiments using Akt1 gene-deficient neu-
rons and transfected hippocampal neurons. Ectopic ex- of excitotoxic signaling. Taken together, these studies
suggest a model in which kainate elicits JNK activationpression of Akt1 constructs capable of binding JIP1
attenuated kainate-induced apoptosis while Akt1 gene in a JIP1-dependent manner, leading to phosphorylation
of c-jun and subsequent apoptosis.deletion rendered neurons more sensitive to this excito-
toxic stimulus than wild-type neurons. In addition to kainate exposure, ultraviolet radiation
also decreased the amount of Akt1 in JIP1 immunopre-Experiments using mutant mice have uncovered sev-
eral critical elements of the kainate-induced cell death cipitates in transfected COS7 cells (data not shown),
suggesting a more general role for Akt1-JIP1 dissocia-pathway. Mice genetically deficient in JNK3, a relatively
neuron-specific JNK family member, exhibit no appar- tion under conditions of cell stress. These results raise
the possibility that JNK activity may also govern Akt1-ent developmental abnormalities but demonstrate in-
creased resistance to kainate-induced neuronal death JIP1 interactions. However, JNK activity by itself is not
sufficient to dissociate Akt1 from JIP1 (Figure 5B). Wecompared to wild-type mice in vitro and in vivo (Whit-
marsh et al., 2001; Yang et al., 1997). An important down- also found that kainate-induced dissociation of the com-
plex did not coincide with a change in Akt1 activity.stream nuclear target of JNK is the c-jun transcription
factor, which is activated upon phosphorylation by JNK Additionally, BDNF-induced activation of Akt1 in primary
Neuron
706
Figure 8. Model of Kainate-Induced Forma-
tion of JNK Scaffold Complexes and Apo-
ptosis
(A) In the basal state, Akt1 binds JIP1, pre-
venting formation of JIP1-mediated, proapo-
ptotic JNK complexes.
(B) Upon excitotoxic kainate stimulation, Akt1
dissociates from JIP1, leading to JIP1 associ-
ation with the JNK pathway, nuclear accumu-
lation of active JNK, and subsequent apo-
ptosis.
neurons did not alter Akt1-JIP1 binding. Together, these phosphorylation and MLK3 activation, as mentioned
above (Figures 4 and 5). JNK has been demonstrateddata indicate that Akt1 activity does not affect Akt1
binding to and dissociation from JIP1. to phosphorylate JIP family members (Kelkar et al.,
2000). In the presence of Akt1, the decreased mobility—The assembly of MLK, MKK7, and JNK by JIP1 has
been proposed to allow efficient sequential phosphory- and presumably phosphorylation—of JIP1 and MLK3
proteins was considerably reversed (Figures 4 and 5).lation of these kinases (Davis, 2000; Whitmarsh et al.,
1998). A recent model postulates that JIP1 binds an Therefore, Akt1 binding to JIP1 may affect a proximal
step in the molecular activation of the JNK scaffold.MLK, specifically DLK, in an inactive, monomeric state
and that JNK releases MLK from JIP1, allowing MLK For instance, Akt1 binding may prevent the putative
phosphorylation of JIP1 or, alternatively, prevent effec-dimerization, activation, and subsequent reinforcement
of JNK activity (Nihalani et al., 2000). An intriguing aspect tive activation of JIP1-bound MLK3.
Akt kinase activity has been well established as aof this model is the hypothesis that JNK lies both up-
stream and downstream of MLK signaling in the context prosurvival signal in various cell systems, including pri-
mary central neurons (Datta et al., 1999; Dudek et al.,of JIP1 scaffolding. As with other MLK family members,
the extent of MLK3’s catalytic activity is associated with 1997). A growing number of Akt substrates involved in
mediating survival signaling have been identified, in-its degree of autophosphorylation (Bock et al., 2000;
Nihalani et al., 2000). Consistently, we observed de- cluding GSK-3, BAD, caspase 9, Forkhead transcription
factors, ASK1, and MKK4 (Brunet et al., 1999; Cardonecreased MLK3 protein migration by gel electrophoresis
in the presence of both JNK and JIP1 compared to et al., 1998; Cross et al., 1995; Datta et al., 1997; del
Peso et al., 1997; Hetman et al., 2000; Kim et al., 2001;JIP1 alone, suggesting that JNK helps to promote MLK3
autophosphorylation and activation (Figures 4 and 5). Park et al., 2002; Rena et al., 1999). In our experiments,
ambient neuronal death did tend to increase in the pres-We also conducted in vitro MLK3 phosphorylation ex-
periments using JIP1 immunoprecipitates containing ence of ectopic kinase-dead Akt1 (Figure 7), confirming
the Akt kinase-mediated trophic effects reported pre-MLK3. Addition of wild-type but not kinase-dead recom-
binant JNK3 increased the phosphorylation status of viously (Datta et al., 1999; Dudek et al., 1997). However,
in the context of excitatory cell death, Akt1 catalyticJIP1-bound MLK3 (data not shown), suggesting a role
for JNK activity in the activation of MLK3. Therefore, activity does not play a predominant role, since (1) kai-
nate did not diminish Akt activity in primary neurons, andalthough JIP1 can assemble MLK3 and JNK simultane-
ously (in contrast to DLK), full activation of JNK appears (2) a kinase-dead Akt1 inhibited both JNK scaffolding as
well as neuronal death. These results suggest that Aktto require prior activation of MLK3 by JNK through a
JIP1-dependent process. kinase-dependent JNK pathway targets, such as ASK1
and MKK4, are less likely to contribute to excitotoxicAkt1-mediated inhibition of the JNK scaffold complex
was associated with disruption of JIP1 binding to MLK3 apoptosis.
Collectively, crosstalk between Akt and JNK basedand JNK only when both JNK pathway kinases were
expressed. In our experiments, potentiation of JNK ac- upon Akt1 binding to JIP1 represents a novel, kinase-
independent survival mechanism for Akt1. The Akt1-tivity correlated with retarded electrophoretic mobility
of both JIP1 and MLK3 protein, consistent with JIP1 JIP1 interaction appears particularly critical during exci-
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Polyclonal anti-GluR6/7, monoclonal anti-PSD-95, and the poly-totoxic neuronal death, a process in which recruitment
clonal anti-JNK3 (which detects both JNKs 1 and 3, used for fractionof JIP1 and activation of proapoptotic JNK play obliga-
immunoblotting) were from Upstate Biotechnology (Lake Placid,tory roles. Our findings therefore demonstrate that ma-
NY). The polyclonal anti-phospho-Akt(S473), anti-phospho-
nipulation of Akt1-mediated protein interactions may Akt(T308), and anti-phospho-JNK (for immunoblotting) were ob-
represent a unique means of altering the balance be- tained from Cell Signaling Technologies (Beverly, MA). The poly-
clonal anti-phospho-JNK used for immunofluorescence was fromtween cellular survival and death.
Biosource (Camarillo, CA), and the polyclonal anti-	-galactosidase
was from 5 Prime-3 Prime (Boulder, CO). Affinity purified anti-JIP1Experimental Procedures
has been described elsewhere (Meyer et al., 1999). Polyclonal anti-
ribophorin was generously provided by Dr. Gert Kreibich.Cell Culture and Transfections
Primary neuronal cultures were prepared as previously described
with minor modifications (Rameau et al., 2000). Rat hippocampal Immunofluorescence Microscopy
and cortical neurons were cultured from embryonic day 18 (E18) Plated cells were fixed on ice with 4% paraformaldehyde in PBS
Sprague-Dawley fetuses (Harlan, Indianapolis, IN) in plating medium for 10 min, permeabilized with cold methanol for 5 min, and blocked
(minimal essential medium [MEM], 10% fetal bovine serum [FBS], with Tris-buffered saline (pH 8) (TBS) containing 5% FBS, 5% normal
0.45% glucose, 1 mM pyruvate, 25 M glutamine, and penicillin/ goat serum, and 5% bovine serum albumin. Neurons were incubated
streptomycin [Invitrogen, Carlsbad, CA]) for 3 hr and then maintained with the indicated primary antibodies and then Cy3- or FITC-conju-
in serum-free Neurobasal medium plus B27 supplement (Invitrogen) gated secondary antibodies (Jackson Labs, West Grove, PA), both
and 25 M glutamate in a humidified incubator (37C in 5% CO2). in blocking solution. Cell nuclei were labeled with Hoechst 33342
On DIV 3 (days in vitro), 5-fluoro-2-deoxyuridine was added to the (Molecular Probes, Eugene, OR). Immunolabeled proteins and
medium to inhibit the proliferation of nonneuronal cells for 3 days. stained nuclei were visualized by fluorescence microscopy (Zeiss)
Neurons were cotransfected with the indicated plasmids using Lipo- or confocal fluorescence microscopy (Leica, Heidelberg, Germany).
fectamine 2000 (Invitrogen) for 90 min and then incubated for 20–24
hr in medium containing 50% conditioned medium plus penicillin/
Subcellular Fractionation
streptomycin. Mouse hippocampo-cortical neurons were prepared
Primary hippocampal neurons (DIV 11) were homogenized using a
from E15–E16 fetuses by single-embryo dissection and cultured in
Dounce homogenizer in buffer H (250 mM sucrose, 20 mM Tricine-
the same fashion as rat neurons in a humidified incubator at 37C
NaOH [pH7.8], 1 mM EDTA, 2 mM MgCl2, with protease and phos-in 7.5% CO2. Each embryo was subjected to genotyping by PCR as phatase inhibitors). Membrane fractions were prepared by sequen-
described previously (Cho et al., 2001).
tial centrifugation as described in Figure 1E (top). For discontinuous
Human embryonic kidney 293 and COS7 cells were cultured at
gradients, the P2 pellet (6.0 106 cells) was adjusted to 25% iodixa-
37C in 5% CO2 in Dulbecco’s modified Eagle’s medium (DMEM) nol (Optiprep, Accurate, Westbury, NY) and overlaid with 20%, 15%,
(Invitrogen) containing 10% FBS and penicillin/streptomycin. For
10%, and 5% iodixanol in buffer H. Gradients were centrifuged either
transient transfection, cells were cultured on 6-well plates and trans-
in a SW40Ti rotor (Beckman, Fullerton, CA) at 27,000 rpm for 18 hr
fected with the indicated plasmids using Fugene 6 (Roche, Indianap-
or in a TLS55 rotor (Beckman) at 38,000 rpm for 5 hr at 4C. Also,
olis, IN) for 36 hr. For all experiments, total plasmid DNA amount
P2 fractions (25.0  106 cells) in buffer H were loaded on the top
was equalized by addition of vector pcDNA3.
of an iodixanol linear gradient (0%–25% iodixanol in buffer H). Mem-
brane fractions were collected, and equal volumes were analyzed
Constructs, Recombinant Proteins, and Antibodies by SDS-PAGE and immunoblotting.
pCMV6-hemagglutinin (HA)-tagged wild-type Akt (herein referred to
as Akt1) (HA-Akt1), kinase-dead Akt1 K179M (HA-Akt1KD) (Franke
Immunoprecipitation and Immunoblottinget al., 1997), Akt1 E40K (HA-Akt1E40K) (Cardone et al., 1998), and
For endogenous coimmunoprecipitations, treated neurons (1  107myristoylated Akt1 (myr-Akt1-HA) (Ahmed et al., 1997), Akt1 mutants
cells) were lysed in 1% NP-40 lysis buffer (with 20 mM Tris [pH 8], 150deleted in amino acids (aa) 11–60 (HA-Akt111-60) or in aa 113–146
mM NaCl, 10% glycerol, 1 mM EDTA, 20 mM	-glycerophosphate, 10(HA-Akt1113-146) (kind gifts of Dr. Thomas Franke) (Bellacosa et
mM NaF, 1 mM sodium orthovanadate, 1 mM PMSF, and 1.5%al., 1998), and pRC-	-galactosidase (	-gal) (Kim et al., 2001) have
aprotinin). Clarified lysates were precleared with protein G agarosebeen described. pcDNA3-HA-tagged mouse Akt2 (HA-Akt2),
(Roche) and immunoprecipitated using anti-Akt1 C-20 (with or with-pCMV5-HA-tagged Akt1 T308D/S473D (HA-Akt1TS/DD) (Bellacosa
out preincubation with Akt1 peptide) or anti-JNK1 C-17 followed byet al., 1998), and an Akt1 mutant encoding aa 1–147 (HA-AH) (Datta
protein G agarose. Pellets were washed five times with lysis bufferet al., 1995) were generously provided by Drs. Philip Tsichlis and
plus phosphatase inhibitors. After SDS-PAGE and PVDF (Millipore,Tung Chan. The pcDNA3-HA-tagged Akt1 mutant deleted in amino
Bedford, MA) transfer, proteins were visualized by immunoblottingacids 1–250 (HA-Akt1250) was generated by standard PCR and
using the indicated antibodies followed by enhanced chemilumines-cloning methods. pRK5-myc-tagged human JIP1 (myc-JIP1) (Verhey
cence (Amersham Pharmacia Biotech). For 293 or COS7 coimmuno-et al., 2001), HA-tagged JNK1 (HA-JNK1) and pCS3-myc-tagged
precipitation experiments, cells transfected with the indicated con-MKK7 (myc-MKK7) (Holland et al., 1997) (gifts of Dr. Ed Skolnik),
structs were lysed in 1% NP-40 lysis buffer. Clarified lysates wereand FLAG-tagged MLK3 (FLAG-MLK3) (a gift of Dr. Larry Holzman)
subjected to immunoprecipitation using the indicated antibodies(Tibbles et al., 1996) have been described. The JIP1 deletion mutants
followed by protein A sepharose (Sigma) or protein G agarose. Pel-(depicted in Figure 3B) were produced by PCR using JIP1 cDNA as
lets were washed seven times with lysis buffer, and proteins werea template and then subcloned into pcDNA3-FLAG. Full-length Akt1
visualized by immunoblotting as described above. Mouse neuronscDNA was subcloned distal to a GST-encoding sequence (pGEX-
were lysed directly in Laemmli sample buffer.6P) using standard cloning procedures (GST-Akt1), and bacterially
expressed protein was produced and isolated according to manu-
facturer’s instructions (Amersham Pharmacia Biotech, Piscata- GST Pulldown Assays
Using the pcDNA3-FLAG-JIP1 deletion mutant plasmids, 35S-labeledway, NJ).
Anti-HA 3F10 and 12CA5 were from Roche, and anti-FLAG M2 product was in vitro translated with the TNT-coupled reticulocyte
lysate system (Promega, Madison, WI). Following translation, 35S-was from Sigma (St. Louis, MO). Anti-myc 9E10 and A-14, anti-Akt1
C-20 and corresponding blocking peptide, anti-Akt1 B-1, and anti- labeled proteins were incubated in 1% NP-40 lysis buffer at 4C
for 16 hr with GST alone or GST-Akt1 prebound to glutathione-JNK1 C-17 (anti-JNK1/3, which detects JNK1 46 kDa and JNK3 46
and 54 kDa) were from Santa Cruz Biotechnology (Santa Cruz, CA). sepharose beads (Amersham Pharmacia Biotech). The beads were
then washed with lysis buffer and boiled in 1 Laemmli sampleThe monoclonal anti-Akt1 used for immunofluorescence and immu-
noblotting of fractions and mouse neuronal lysates was from BD buffer. Proteins were resolved by SDS-PAGE, and 35S-labeled pro-
teins were visualized by autoradiography with signal enhancementBiosciences (San Jose, CA). Monoclonal anti-MAP2 and polyclonal
anti-GluR2 was obtained from Chemicon (Temecula, California). (Amplify, Amersham Pharmacia Biotech). Levels of GST-fusion pro-
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teins were assessed by Coomassie blue RC50 staining (Amersham Brunet, A., Bonni, A., Zigmond, M.J., Lin, M.Z., Juo, P., Hu, L.S.,
Anderson, M.J., Arden, K.C., Blenis, J., and Greenberg, M.E. (1999).Pharmacia Biotech).
Akt promotes cell survival by phosphorylating and inhibiting a Fork-
head transcription factor. Cell 96, 857–868.Cell Death Assays
For rat hippocampal neurons, cells were plated on 8-well Permanox Cardone, M.H., Roy, N., Stennicke, H.R., Salvesen, G.S., Franke,
chamber slides (Fisher, Suwanne, GA) (2  104 cells/well) and co- T.F., Stanbridge, E., Frisch, S., and Reed, J.C. (1998). Regulation of
transfected on DIV10 with 	-gal marker plasmid plus the indicated cell death protease caspase-9 by phosphorylation. Science 282,
constructs (1:2 DNA g ratio) as described above. The next day, 1318–1321.
neurons were treated with vehicle (1:1000 dilution of 0.25 N NaOH) Cerezo, A., Martinez, A.C., Lanzarot, D., Fischer, S., Franke, T.F.,
or kainate (Sigma) as indicated. Neurons were then fixed and sub- and Rebollo, A. (1998). Role of Akt and c-Jun N-terminal kinase 2
jected to indirect immunofluorescence with anti-	-gal. In initial in apoptosis induced by interleukin-4 deprivation. Mol. Biol. Cell 9,
experiments, neurons cotransfected with marker plasmid and epi- 3107–3118.
tope-tagged constructs were costained with anti-	-gal and anti-
Cheng, J.Q., Godwin, A.K., Bellacosa, A., Taguchi, T., Franke, T.F.,epitope-tag (anti-HA and anti-FLAG) to assess the reliability of 	-gal
Hamilton, T.C., Tsichlis, P.N., and Testa, J.R. (1992). AKT2, a putativeas a transfection marker. Results from these experiments demon-
oncogene encoding a member of a subfamily of protein-serine/strated nearly 90% concordance between 	-gal-positive and HA/
threonine kinases, is amplified in human ovarian carcinomas. Proc.FLAG-positive neurons. 	-gal-positive neurons were then assessed
Natl. Acad. Sci. USA 89, 9267–9271.in a blind fashion for apoptotic cell death by scoring (1) condensed
Cheng, J., Yang, J., Xia, Y., Karin, M., and Su, B. (2000). Synergisticand/or fragmented nuclei by Hoechst 33342 staining and (2) frag-
interaction of MEK kinase 2, c-Jun N-terminal kinase (JNK) kinasemented 	-gal-positive neurites. 100 	-gal-positive neurons were
2, and JNK1 results in efficient and specific JNK1 activation. Mol.counted per well.
Cell. Biol. 20, 2334–2342.For the lactate dehydrogenase (LDH)-based cell death assays,
neurons were cultured on 48-well plates (mouse: one-third of a Cho, H., Thorvaldsen, J.L., Chu, Q., Feng, F., and Birnbaum, M.J.
hemisphere per 12 wells, rat: 2.4  106 cells/plate). On DIV 10 (2001). Akt1/PKBalpha is required for normal growth but dispensable
(mouse) or 11 (rat), cells were exposed to vehicle or kainate as for maintenance of glucose homeostasis in mice. J. Biol. Chem.
indicated. A23187 (30 M) exposures were conducted for 24 hr 276, 38349–38352.
at 37C in fresh medium after vehicle treatment. ZVAD(O-methyl)- Choi, D.W. (1992). Excitotoxic cell death. J. Neurobiol. 23, 1261–
fluoromethylketone (ZVAD-FMK, Enzyme Systems Products, Liv- 1276.
ermore, CA) was added to the medium as indicated. Cell death was
Cross, D.A., Alessi, D.R., Cohen, P., Andjelkovich, M., and Hem-
quantified by measuring LDH released by dead cells into the cell
mings, B.A. (1995). Inhibition of glycogen synthase kinase-3 by insu-
medium (Cytotox 96, Promega) (Koh and Choi, 1987), a conse-
lin mediated by protein kinase B. Nature 378, 785–789.
quence of the secondary necrosis that apoptotic cells undergo in
Datta, K., Franke, T.F., Chan, T.O., Makris, A., Yang, S.I., Kaplan,the absence of phagocytes. Basal cell death (over 24 hr) and the
D.R., Morrison, D.K., Golemis, E.A., and Tsichlis, P.N. (1995). AH/near complete neuronal death induced by A23187 (Kim et al., 2000)
PH domain-mediated interaction between Akt molecules and itsare presented as LDH activity (optical density [OD] units). For kainate
potential role in Akt regulation. Mol. Cell. Biol. 15, 2304–2310.treatments, LDH values were normalized by subtracting the back-
Datta, S.R., Dudek, H., Tao, X., Masters, S., Fu, H., Gotoh, Y., andground LDH released by vehicle-treated cells from kainate-treated
Greenberg, M.E. (1997). Akt phosphorylation of BAD couples sur-cells and scaling to the signal associated with complete cell death
vival signals to the cell-intrinsic death machinery. Cell 91, 231–241.(set at 100) induced by A23187.
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